Akaza Hideyuki, Kawahara Norie, Nakagama Hitoshi, Noda Tetsuo
UICC-Japan Office.
Gan To Kagaku Ryoho. 2018 Sep;45(9):1259-1277.
UICC-Asia Regional Office(UICC-ARO)successfully convened a fruitful Multi-stakeholder Dialogue at United Nations University in Aoyama, Tokyo, which brought together parliamentarians, representatives ofthe WHO and Japanese government agencies and NGOs, senior executives ofpharmaceutical and other companies, and leading members ofJapan 's cancer research community. This meeting provided a valuable opportunity for stakeholders from all sectors of society to discuss ways in which Japan can develop a multi-sectoral approach that will promote access to cancer care and support initiatives for UHC for cancer in Asia. UICC-ARO Director Hideyuki Akaza and Haruhiko Hirate(Chair of International Affairs Committee, JPMA) co-chaired the meeting. At the outset it was noted that with cancer now firmly on the global health agenda with the adoption ofthe WHA Cancer Resolution, countries around the world are coming to grips with the necessity for concerted and cooperative action on cancer prevention and control. This dialogue marks the first step in efforts to pool resources and information, and noted that with various key international meetings due to be held in 2018 and 2019, now was the time to coalesce opinions and identify a concrete direction for action.
国际抗癌联盟亚洲区域办事处（UICC - ARO）在东京青山的联合国大学成功召开了一场富有成效的多方利益相关者对话会，与会者包括议员、世界卫生组织代表、日本政府机构及非政府组织代表、制药及其他公司的高级管理人员以及日本癌症研究界的主要成员。这次会议为社会各界的利益相关者提供了一个宝贵的机会，以讨论日本如何制定一种多部门方法，促进癌症护理的可及性，并支持亚洲癌症全民健康覆盖倡议。UICC - ARO主任赤座英之与平手治彦（日本制药工业协会国际事务委员会主席）共同主持了会议。会议一开始就指出，随着世界卫生大会癌症决议的通过，癌症现已牢牢列入全球卫生议程，世界各国开始认识到在癌症预防和控制方面采取协调一致合作行动的必要性。这次对话标志着汇聚资源和信息努力的第一步，并指出鉴于2018年和2019年将举行各种关键的国际会议，现在是凝聚意见并确定具体行动方向的时候了。
